Open AccessStrategic Perspectives on Improved Anti-Tumor Drug Effects in Combination with Clinically Equivalent or Lower Concentrations of Epigenetic Modifiers, DNA Methyltransferase Inhibitors, and Histone Deacetylase Inhibitors
Author(s) -
Shuko Hakata,
Kouji Okada,
Jun Terashima,
Toshie Gamou,
Wataru Habano,
Shogo Ozawa
Publication year - 2017
Publication title -
journal of cancer science and therapy
Language(s) - English
Resource type - Journals
ISSN - 1948-5956
DOI - 10.4172/1948-5956.1000471
Subject(s) - epigenetics , histone deacetylase , methyltransferase , dna methyltransferase , pharmacology , drug , histone , histone deacetylase inhibitor , histone deacetylase 2 , dna , medicine , computational biology , biology , bioinformatics , chemistry , biochemistry , methylation , gene